Original language | English |
---|---|
Article number | PB2955 |
Number of pages | 1 |
Journal | Journal of Clinical Oncology |
Volume | 42 |
Issue number | 16 |
DOIs | |
Publication status | Published - 1 Jun 2024 |
Event | American Society of Clinical Oncology (ASCO) Annual Meeting 2024 - McCormick Place, Chicago, United States Duration: 31 May 2024 → 4 Jun 2024 https://meetings.asco.org/meetings/2024-asco-annual-meeting/316/program-guide/scheduled-sessions |
Epcore Fl-2: Phase 3 trial of epcoritamab with rituximab and lenalidomide (R<SUP>2</SUP>) vs chemoimmunotherapy or R<SUP>2</SUP> in previously untreated follicular lymphoma.
Kim M. Linton, Philip Thompson, Stefano Luminari, Carla Casulo, Poliana Patah, Lingmin Zeng, J. P. Mei, Neha Dixit, Daniela Hoehn, Emmanuel Bachy
Research output: Contribution to journal › Meeting Abstract › peer-review
1
Downloads
(Pure)